Descriptive analysis of pharmacy services provided after community pharmacy screening.
Identifieur interne : 000031 ( Main/Corpus ); précédent : 000030; suivant : 000032Descriptive analysis of pharmacy services provided after community pharmacy screening.
Auteurs : Karla Lancaster ; Lehana Thabane ; Jean-Eric Tarride ; Gina Agarwal ; Jeff S. Healey ; Roopinder Sandhu ; Lisa DolovichSource :
- International journal of clinical pharmacy [ 2210-7711 ] ; 2018.
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Alberta, Atrial Fibrillation (diagnosis), Community Pharmacy Services (statistics & numerical data), Diabetes Mellitus, Type 2 (diagnosis), Drug Utilization, Female, Humans, Hypertension (diagnosis), Male, Mass Screening, Medication Therapy Management, Ontario, Retrospective Studies, Risk Assessment, Stroke (diagnosis).
- MESH :
- geographic : Alberta, Ontario.
- diagnosis : Atrial Fibrillation, Diabetes Mellitus, Type 2, Hypertension, Stroke.
- statistics & numerical data : Community Pharmacy Services.
- Aged, Aged, 80 and over, Drug Utilization, Female, Humans, Male, Mass Screening, Medication Therapy Management, Retrospective Studies, Risk Assessment.
Abstract
Background Community pharmacies are promising locations for opportunistic screening due to pharmacist accessibility and ability to perform various health and medication management services. Little is known as to the provision of pharmacy services following screening initiatives. Objective To describe provision of pharmacy services for participants following a community pharmacy stroke screening initiative. Setting The Program for the Identification of "Actionable Atrial" Fibrillation Pharmacy initiative took place in 30 pharmacies in Alberta and Ontario, Canada. 1149 participants ≥ 65 were screened for atrial fibrillation, type 2 diabetes, and hypertension. Method Retrospective, secondary analysis of data using participant case-report forms, pharmacy data, and pharmacy claims to describe pharmacy services received by participants post-screening. Main Outcome Measure Number and types of remunerated pharmacy services received by participants post-screening. Results A total of 535/1149 (46.6%) participants screened at their regular pharmacy were included in this analysis. Of these, 165 (30.8%) participants received 229 pharmacy services within 3 months post-screening, including 146 medication reviews, 57 influenza vaccinations, and 21 pharmaceutical opinions. A median (interquartile range, IQR) of 6 (2-11) pharmacy services were delivered, and median (IQR) reimbursement was $187.50 ($67.50-$342.50). Conclusions Approximately one-third of participants received a pharmacy service within 3 months post-screening. Relatively large numbers of annual and follow-up medication reviews were delivered despite low eligibility for annual-only reviews and despite many missed opportunities for pharmacy service provision in at-risk patients. In-pharmacy screening may facilitate provision of some services, namely medication reviews, by providing opportunities to identify patients at-risk.
DOI: 10.1007/s11096-018-0742-5
PubMed: 30474769
Links to Exploration step
pubmed:30474769Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Descriptive analysis of pharmacy services provided after community pharmacy screening.</title><author><name sortKey="Lancaster, Karla" sort="Lancaster, Karla" uniqKey="Lancaster K" first="Karla" last="Lancaster">Karla Lancaster</name><affiliation><nlm:affiliation>McMaster University, 1280 Main St. W., Hamilton, ON, L8S 4L8, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Thabane, Lehana" sort="Thabane, Lehana" uniqKey="Thabane L" first="Lehana" last="Thabane">Lehana Thabane</name><affiliation><nlm:affiliation>McMaster University, 1280 Main St. W., Hamilton, ON, L8S 4L8, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Tarride, Jean Eric" sort="Tarride, Jean Eric" uniqKey="Tarride J" first="Jean-Eric" last="Tarride">Jean-Eric Tarride</name><affiliation><nlm:affiliation>McMaster University, 1280 Main St. W., Hamilton, ON, L8S 4L8, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Agarwal, Gina" sort="Agarwal, Gina" uniqKey="Agarwal G" first="Gina" last="Agarwal">Gina Agarwal</name><affiliation><nlm:affiliation>McMaster University, 1280 Main St. W., Hamilton, ON, L8S 4L8, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Healey, Jeff S" sort="Healey, Jeff S" uniqKey="Healey J" first="Jeff S" last="Healey">Jeff S. Healey</name><affiliation><nlm:affiliation>Population Health Research Institute, 237 Barton St. E., Hamilton, ON, L8L 2X2, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Sandhu, Roopinder" sort="Sandhu, Roopinder" uniqKey="Sandhu R" first="Roopinder" last="Sandhu">Roopinder Sandhu</name><affiliation><nlm:affiliation>University of Alberta, 116 St. and 85th Ave., Edmonton, AB, T6G 2R3, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Dolovich, Lisa" sort="Dolovich, Lisa" uniqKey="Dolovich L" first="Lisa" last="Dolovich">Lisa Dolovich</name><affiliation><nlm:affiliation>McMaster University, 1280 Main St. W., Hamilton, ON, L8S 4L8, Canada. lisa.dolovich@utoronto.ca.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St., Room 607, Toronto, ON, M5S 3M2, Canada. lisa.dolovich@utoronto.ca.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2018">2018</date><idno type="RBID">pubmed:30474769</idno><idno type="pmid">30474769</idno><idno type="doi">10.1007/s11096-018-0742-5</idno><idno type="wicri:Area/Main/Corpus">000031</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000031</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Descriptive analysis of pharmacy services provided after community pharmacy screening.</title><author><name sortKey="Lancaster, Karla" sort="Lancaster, Karla" uniqKey="Lancaster K" first="Karla" last="Lancaster">Karla Lancaster</name><affiliation><nlm:affiliation>McMaster University, 1280 Main St. W., Hamilton, ON, L8S 4L8, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Thabane, Lehana" sort="Thabane, Lehana" uniqKey="Thabane L" first="Lehana" last="Thabane">Lehana Thabane</name><affiliation><nlm:affiliation>McMaster University, 1280 Main St. W., Hamilton, ON, L8S 4L8, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Tarride, Jean Eric" sort="Tarride, Jean Eric" uniqKey="Tarride J" first="Jean-Eric" last="Tarride">Jean-Eric Tarride</name><affiliation><nlm:affiliation>McMaster University, 1280 Main St. W., Hamilton, ON, L8S 4L8, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Agarwal, Gina" sort="Agarwal, Gina" uniqKey="Agarwal G" first="Gina" last="Agarwal">Gina Agarwal</name><affiliation><nlm:affiliation>McMaster University, 1280 Main St. W., Hamilton, ON, L8S 4L8, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Healey, Jeff S" sort="Healey, Jeff S" uniqKey="Healey J" first="Jeff S" last="Healey">Jeff S. Healey</name><affiliation><nlm:affiliation>Population Health Research Institute, 237 Barton St. E., Hamilton, ON, L8L 2X2, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Sandhu, Roopinder" sort="Sandhu, Roopinder" uniqKey="Sandhu R" first="Roopinder" last="Sandhu">Roopinder Sandhu</name><affiliation><nlm:affiliation>University of Alberta, 116 St. and 85th Ave., Edmonton, AB, T6G 2R3, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Dolovich, Lisa" sort="Dolovich, Lisa" uniqKey="Dolovich L" first="Lisa" last="Dolovich">Lisa Dolovich</name><affiliation><nlm:affiliation>McMaster University, 1280 Main St. W., Hamilton, ON, L8S 4L8, Canada. lisa.dolovich@utoronto.ca.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St., Room 607, Toronto, ON, M5S 3M2, Canada. lisa.dolovich@utoronto.ca.</nlm:affiliation></affiliation></author></analytic><series><title level="j">International journal of clinical pharmacy</title><idno type="eISSN">2210-7711</idno><imprint><date when="2018" type="published">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Alberta</term><term>Atrial Fibrillation (diagnosis)</term><term>Community Pharmacy Services (statistics & numerical data)</term><term>Diabetes Mellitus, Type 2 (diagnosis)</term><term>Drug Utilization</term><term>Female</term><term>Humans</term><term>Hypertension (diagnosis)</term><term>Male</term><term>Mass Screening</term><term>Medication Therapy Management</term><term>Ontario</term><term>Retrospective Studies</term><term>Risk Assessment</term><term>Stroke (diagnosis)</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Alberta</term><term>Ontario</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Atrial Fibrillation</term><term>Diabetes Mellitus, Type 2</term><term>Hypertension</term><term>Stroke</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Community Pharmacy Services</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Drug Utilization</term><term>Female</term><term>Humans</term><term>Male</term><term>Mass Screening</term><term>Medication Therapy Management</term><term>Retrospective Studies</term><term>Risk Assessment</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Background Community pharmacies are promising locations for opportunistic screening due to pharmacist accessibility and ability to perform various health and medication management services. Little is known as to the provision of pharmacy services following screening initiatives. Objective To describe provision of pharmacy services for participants following a community pharmacy stroke screening initiative. Setting The Program for the Identification of "Actionable Atrial" Fibrillation Pharmacy initiative took place in 30 pharmacies in Alberta and Ontario, Canada. 1149 participants ≥ 65 were screened for atrial fibrillation, type 2 diabetes, and hypertension. Method Retrospective, secondary analysis of data using participant case-report forms, pharmacy data, and pharmacy claims to describe pharmacy services received by participants post-screening. Main Outcome Measure Number and types of remunerated pharmacy services received by participants post-screening. Results A total of 535/1149 (46.6%) participants screened at their regular pharmacy were included in this analysis. Of these, 165 (30.8%) participants received 229 pharmacy services within 3 months post-screening, including 146 medication reviews, 57 influenza vaccinations, and 21 pharmaceutical opinions. A median (interquartile range, IQR) of 6 (2-11) pharmacy services were delivered, and median (IQR) reimbursement was $187.50 ($67.50-$342.50). Conclusions Approximately one-third of participants received a pharmacy service within 3 months post-screening. Relatively large numbers of annual and follow-up medication reviews were delivered despite low eligibility for annual-only reviews and despite many missed opportunities for pharmacy service provision in at-risk patients. In-pharmacy screening may facilitate provision of some services, namely medication reviews, by providing opportunities to identify patients at-risk.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30474769</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2210-7711</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>6</Issue><PubDate><Year>2018</Year><Month>Dec</Month></PubDate></JournalIssue><Title>International journal of clinical pharmacy</Title><ISOAbbreviation>Int J Clin Pharm</ISOAbbreviation></Journal><ArticleTitle>Descriptive analysis of pharmacy services provided after community pharmacy screening.</ArticleTitle><Pagination><MedlinePgn>1577-1586</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11096-018-0742-5</ELocationID><Abstract><AbstractText>Background Community pharmacies are promising locations for opportunistic screening due to pharmacist accessibility and ability to perform various health and medication management services. Little is known as to the provision of pharmacy services following screening initiatives. Objective To describe provision of pharmacy services for participants following a community pharmacy stroke screening initiative. Setting The Program for the Identification of "Actionable Atrial" Fibrillation Pharmacy initiative took place in 30 pharmacies in Alberta and Ontario, Canada. 1149 participants ≥ 65 were screened for atrial fibrillation, type 2 diabetes, and hypertension. Method Retrospective, secondary analysis of data using participant case-report forms, pharmacy data, and pharmacy claims to describe pharmacy services received by participants post-screening. Main Outcome Measure Number and types of remunerated pharmacy services received by participants post-screening. Results A total of 535/1149 (46.6%) participants screened at their regular pharmacy were included in this analysis. Of these, 165 (30.8%) participants received 229 pharmacy services within 3 months post-screening, including 146 medication reviews, 57 influenza vaccinations, and 21 pharmaceutical opinions. A median (interquartile range, IQR) of 6 (2-11) pharmacy services were delivered, and median (IQR) reimbursement was $187.50 ($67.50-$342.50). Conclusions Approximately one-third of participants received a pharmacy service within 3 months post-screening. Relatively large numbers of annual and follow-up medication reviews were delivered despite low eligibility for annual-only reviews and despite many missed opportunities for pharmacy service provision in at-risk patients. In-pharmacy screening may facilitate provision of some services, namely medication reviews, by providing opportunities to identify patients at-risk.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lancaster</LastName><ForeName>Karla</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>McMaster University, 1280 Main St. W., Hamilton, ON, L8S 4L8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thabane</LastName><ForeName>Lehana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>McMaster University, 1280 Main St. W., Hamilton, ON, L8S 4L8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarride</LastName><ForeName>Jean-Eric</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>McMaster University, 1280 Main St. W., Hamilton, ON, L8S 4L8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Gina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>McMaster University, 1280 Main St. W., Hamilton, ON, L8S 4L8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Healey</LastName><ForeName>Jeff S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Population Health Research Institute, 237 Barton St. E., Hamilton, ON, L8L 2X2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandhu</LastName><ForeName>Roopinder</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Alberta, 116 St. and 85th Ave., Edmonton, AB, T6G 2R3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dolovich</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-0061-6783</Identifier><AffiliationInfo><Affiliation>McMaster University, 1280 Main St. W., Hamilton, ON, L8S 4L8, Canada. lisa.dolovich@utoronto.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St., Room 607, Toronto, ON, M5S 3M2, Canada. lisa.dolovich@utoronto.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Clin Pharm</MedlineTA><NlmUniqueID>101554912</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000416" MajorTopicYN="N" Type="Geographic">Alberta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003157" MajorTopicYN="N">Community Pharmacy Services</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004363" MajorTopicYN="N">Drug Utilization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054539" MajorTopicYN="N">Medication Therapy Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Canada</Keyword><Keyword MajorTopicYN="N">Chronic disease</Keyword><Keyword MajorTopicYN="N">Mass screening</Keyword><Keyword MajorTopicYN="N">Medication</Keyword><Keyword MajorTopicYN="N">Pharmaceutical services</Keyword><Keyword MajorTopicYN="N">Pharmacies</Keyword><Keyword MajorTopicYN="N">Review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>04</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30474769</ArticleId><ArticleId IdType="doi">10.1007/s11096-018-0742-5</ArticleId><ArticleId IdType="pii">10.1007/s11096-018-0742-5</ArticleId><ArticleId IdType="pmc">PMC6280862</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000031 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000031 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeCanadaV3
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:30474769
|texte= Descriptive analysis of pharmacy services provided after community pharmacy screening.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:30474769" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV3
| This area was generated with Dilib version V0.6.35. |  |